Details of the Drug
General Information of Drug (ID: DMLT7FQ)
Drug Name |
Erythose-4-Phosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
D-Erythrose 4-phosphate; erythrose 4-phosphate; threose 4-phosphate; ERYTHOSE-4-PHOSPHATE; D-erythrose-4-phosphate; 585-18-2; erythrose-4-phosphate; erythrose-4P; erythrose-4-P; D-erythrose-4-P; UNII-2156QF7O8M; CHEBI:48153; 2156QF7O8M; (2R,3R)-2,3-dihydroxy-4-oxobutyl dihydrogen phosphate; E4P; Butanal, 2,3-dihydroxy-4-(phosphonooxy)-, (R-(R*,R*))-; 4-D-erythrosephosphoric acid; Erythrose 4-PO4; D-Erythrose 4-PO4; AC1L3UFJ; 4-O-phosphono-D-erythrose; SCHEMBL50110; AC1Q6S62; butanal, 2,3-dihydroxy-4-(phosphonooxy)-,(2r,3r)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 200.08 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -3.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||